Intragel TherapeuticsIntragel Therapeutics
Intragel Therapeutics

Intragel Therapeutics

Pharma company developing long-acting injectable drug delivery systems for challenging molecules.

2021Inactive10

About

IntraGel Therapeutics is a pharmaceutical company focused on the development of long-acting and local delivery systems for challenging small molecule drugs, peptides, and anti-neoplasm agents. They have created a unique injectable polymeric platform called SRGel for sustained release.

Technology stack

detected 2026-06-09
Est. monthly stack spend~$140/mo
EmailMicrosoft 365
Hosting
Google Cloud
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Intragel Therapeutics do?

IntraGel Therapeutics is a pharmaceutical company focused on the development of long-acting and local delivery systems for challenging small molecule drugs, peptides, and anti-neoplasm agents. They have created a unique injectable polymeric platform called SRGel for sustained release.

Where is Intragel Therapeutics headquartered?

Intragel Therapeutics is headquartered in Nazareth, Israel.

When was Intragel Therapeutics founded?

Intragel Therapeutics was founded in 2021.

What industry does Intragel Therapeutics operate in?

Intragel Therapeutics operates in Life Sciences, Biotech, Drug Discovery, Clinical Trials, HealthTech, Pharmaceuticals.

How many employees does Intragel Therapeutics have?

Intragel Therapeutics has approximately 10 people on record.

What is Intragel Therapeutics's current status?

Intragel Therapeutics's current operating status is: Inactive.